JAMDA
Volume 11, Issue 3 , Pages 159-160 , March 2010

Risk of Venous Thromboembolism in Long-Term Care Residents: What Do We Know Now?

  • Barbara J. Messinger-Rapport, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Barbara J. Messinger-Rapport, MD, PhD, CMD, FACP, Geriatric Medicine Fellowship, Center for Geriatric Medicine of the Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk G10, Cleveland, OH 44195.

References 

  1. Zarowitz B, Tangelos E, Lefkovitz A, et al. Thrombotic risk and immobility in residents of long-term care facilities. J Am Med Dir Assoc. 2010;11:211–221
  2. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:381S–453S
  3. Grady D, Wenger N, Herrington DM, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2000;132:689–696
  4. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study. J Thromb Thrombolysis. 2006;22:31–38
  5. Hull RD. EXCLAIM: Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization. Available at: http://www.clinicalstudyresults.org/drugdetails/?sort=inn.inn_name&page=7&drug_id=3424. Accessed January 18, 2010.
  6. Vaitkus PT, Leizorovicz A, Goldhaber SZ, Group PI. Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: The prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study). Vasc Med. 2002;7:269–273
  7. Leizorovicz A, Cohen AT, Turpie AG, et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004;110:874–879
  8. Kucher N, Leizorovicz A, Vaitkus PT, et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: A subgroup analysis of the PREVENT trial. Arch Intern Med. 2005;165:341–345
  9. Ray JG, Lonn E, Yi Q, et al. Venous thromboembolism in association with features of the metabolic syndrome. QJM. 2007;100:679–684
  10. Petersen LJ. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines. Cancer Treat Rev. 2009;35:754–764
  11. Phillips SM, Gallagher M, Buchan H. Use graduated compression stockings postoperatively to prevent deep vein thrombosis. BMJ. 2008;336:943–944
  12. Amaragiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2000;(3):CD001484

PII: S1525-8610(10)00034-4

doi: 10.1016/j.jamda.2010.01.008

JAMDA
Volume 11, Issue 3 , Pages 159-160 , March 2010

Article Tools